On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ...
WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and ...
Rhumbline Advisers lifted its holdings in shares of Zura Bio Limited (NASDAQ:ZURA – Free Report) by 37.3% during the 4th quarter, according to its most recent 13F filing with the Securities and ...
Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and life-threatening ...
CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 -- -- Advancing four clinical programs for hematologic malignancies and autoimmune diseases -- -- $249.4 ...
In the biotechnology and chemical spaces, genus claims are often sought by patent applicants to protect not only a specific product of interest, ...
After hours: March 14 at 6:28:29 PM EDT Loading Chart for ZURA ...
Head of Electron Microscopy Research & Development, Ph.D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results